M9 Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies
Course content
Using a combination of theory and hands-on instruction, participants will learn the following:
- Key best practices and methods for vaccine process development from upstream to downstream focusing on a viral vaccine platform.
-
Best practices of cell culturing in single use bioreactors for both adherent and suspension cells;
-
Optimization of filtration and purification technologies;
-
Adjuvant filtration;
- How to integrate vaccine processes in a single use environment;
Learning Outcomes
Understand challenges and integrate key considerations for optimal viral vaccine process development and transition to manufacturing Learn how to implement a single use technology based process for viral vaccines.
Who should apply
This course is designed for R&D scientists and engineers who are or will be responsible for developing and implementing production scale viral vaccine processes.
Minimal requirements
Prior experience with laboratory scale vaccine and/or biologics process development.
Accommodation
Accommodation will be provided. Travel costs are not included.
Course Goals
Process development and scale-up of viral vaccines.
Timeline
Application Deadline:
1 May 2021
Course Dates:
Q3 2021 (2 days)
Organiser
Vaccine Formulation Insitute (VFI) in collaboration with Merck/M Lab, Molsheim, France
Participant Nr.: 10